Page last updated: 2024-08-24

capecitabine and Obesity

capecitabine has been researched along with Obesity in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dijksterhuis, WPM; Klaassen, R; Kurk, SA; Pruijt, MJ; van der Woude, SO; van Laarhoven, HWM; van Oijen, MGH	1
Avallone, A; Capozzi, M; Capuozzo, M; Casaretti, R; Cassata, A; De Divitiis, C; Iaffaioli, VR; Maiolino, P; Nappi, A; Nasti, G; Ottaiano, A; Quagliariello, V; Romano, C; Scala, S; Silvestro, L; Tafuto, S	1
Denkert, C; Eiermann, W; Furlanetto, J; Lederer, B; Loibl, S; Marmé, F; Möbus, V; Nekljudova, V; Reimer, T; Reinisch, M; Schmatloch, S; Stickeler, E; Thomssen, C; Untch, M; von Minckwitz, G; Weber, K	1
Derleyn, VA; Koopman, M; Mol, L; Muller, EW; Punt, CJ; Simkens, LH; Teerenstra, S; Ten Bokkel Huinink, D; Veldhuis, GJ	1

Trials

2 trial(s) available for capecitabine and Obesity

Article	Year
Higher rate of severe toxicities in obese patients receiving dose-dense (dd) chemotherapy according to unadjusted body surface area: results of the prospectively randomized GAIN study. Annals of oncology : official journal of the European Society for Medical Oncology, 2016, Volume: 27, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Body Surface Area; Breast Neoplasms; Capecitabine; Cyclophosphamide; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Epirubicin; Febrile Neutropenia; Female; Humans; Lymphatic Metastasis; Obesity; Taxoids	2016
Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapy. European journal of cancer (Oxford, England : 1990), 2011, Volume: 47, Issue:17 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Camptothecin; Capecitabine; Chemotherapy, Adjuvant; Colorectal Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Irinotecan; Male; Middle Aged; Molecular Targeted Therapy; Obesity; Organoplatinum Compounds; Oxaliplatin; Retrospective Studies; Survival Analysis; Treatment Outcome	2011

Article

Year

Higher rate of severe toxicities in obese patients receiving dose-dense (dd) chemotherapy according to unadjusted body surface area: results of the prospectively randomized GAIN study.

Annals of oncology : official journal of the European Society for Medical Oncology, 2016, Volume: 27, Issue:11

Topics: Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Body Surface Area; Breast Neoplasms; Capecitabine; Cyclophosphamide; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Epirubicin; Febrile Neutropenia; Female; Humans; Lymphatic Metastasis; Obesity; Taxoids

2016

Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapy.

European journal of cancer (Oxford, England : 1990), 2011, Volume: 47, Issue:17

Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Camptothecin; Capecitabine; Chemotherapy, Adjuvant; Colorectal Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Irinotecan; Male; Middle Aged; Molecular Targeted Therapy; Obesity; Organoplatinum Compounds; Oxaliplatin; Retrospective Studies; Survival Analysis; Treatment Outcome

2011

Other Studies

2 other study(ies) available for capecitabine and Obesity

Article	Year
Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy. Journal of cachexia, sarcopenia and muscle, 2019, Volume: 10, Issue:1 Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Composition; Capecitabine; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Muscle, Skeletal; Obesity; Oxaliplatin; Palliative Care; Sarcopenia; Stomach Neoplasms	2019
Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy. Oncology, 2016, Volume: 90, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Capecitabine; Chemotherapy, Adjuvant; Chronic Disease; Colonic Neoplasms; Diabetes Complications; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Obesity; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Prognosis	2016

Article

Year

Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy.

Journal of cachexia, sarcopenia and muscle, 2019, Volume: 10, Issue:1

Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Composition; Capecitabine; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Muscle, Skeletal; Obesity; Oxaliplatin; Palliative Care; Sarcopenia; Stomach Neoplasms

2019

Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy.

Oncology, 2016, Volume: 90, Issue:1

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Capecitabine; Chemotherapy, Adjuvant; Chronic Disease; Colonic Neoplasms; Diabetes Complications; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Obesity; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Prognosis

2016